Back
CRISPR Therapeutics AG Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49
CRSP
CRISPR Therapeutics AG
Last Price:
$49.51
Seasonality Move:
24.59%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.13 | Buy |
| 20-day SMA: | 48.95 | Buy |
| 50-day SMA: | 51.94 | Sell |
| 200-day SMA: | 56.19 | Sell |
| 8-day EMA: | 47.79 | Buy |
| 20-day EMA: | 49.06 | Buy |
| 50-day EMA: | 51.45 | Sell |
| 200-day EMA: | 53.34 | Sell |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.64 | Sell |
| Relative Strength Index (14 RSI): | 49.23 | Sell |
| Chaikin Money Flow: | 1192288 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.84 - 56.18) | Sell |
| Bollinger Bands (100): | (49.47 - 57.17) | Sell |
CRISPR Therapeutics AG Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 49.51 while CRSP 8-day simple moving average is 47.13, which is a Buy signal.
-
The stock price of CRSP is 49.51 while CRISPR Therapeutics AG 20-day SMA is 48.95, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day simple moving average is 51.94 while CRSP share price is 49.51, making it a Sell technically.
-
CRSP stock price is 49.51 and CRISPR Therapeutics AG 200-day simple moving average is 56.19, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
49
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a SellThe current CRISPR Therapeutics AG [CRSP] share price is $49.51. The Score for CRSP is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
4.8B
Price in USD:
49.51
Share Volume:
1.7M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
78.48
52-Week Low:
30.04
Sell
49
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 49.51 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 49.51 while CRSP 8-day exponential moving average is 47.79, which is a Buy signal.
-
The stock price of CRSP is 49.51 while CRISPR Therapeutics AG 20-day EMA is 49.06, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day exponential moving average is 51.45 while CRSP share price is 49.51, making it a Sell technically.
-
CRSP stock price is 49.51 and CRISPR Therapeutics AG 200-day simple moving average is 53.34, creating a Sell signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.15 per share, an increase this year of $1.23 per share, and an increase next year of $0.75 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is -1.64, suggesting CRISPR Therapeutics AG is a Sell
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 49.23, which suggest CRISPR Therapeutics AG is oversold
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (45.84 - 56.18), which suggest CRISPR Therapeutics AG is a Sell
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (49.47 - 57.17), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.